Novocure
NVCR
#4874
Rank
A$2.72 B
Marketcap
Country
A$23.50
Share price
1.93%
Change (1 day)
-14.71%
Change (1 year)
Categories

Revenue for Novocure (NVCR)

Revenue in 2025 (TTM): A$1.00 Billion

According to Novocure 's latest financial reports the company's current revenue (TTM ) is A$0.90 Billion. an increase over the revenue in the year 2024 that were of A$0.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novocure from 2015 to 2025

Annual revenue

Year Revenue Change
2025 A$0.97 B0.56%
2024 A$0.97 B30.15%
2023 A$0.74 B-5.41%
2022 A$0.79 B7.1%
2021 A$0.73 B14.79%
2020 A$0.64 B28.13%
2019 A$0.50 B42.5%
2018 A$0.35 B55.29%
2017 A$0.22 B97.19%
2016 A$0.11 B153.18%
2015 A$45.41 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
A$0.19 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$30.29 M-96.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.50 B 65.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
A$0.90 B 0.00% Jersey